搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Aspergillus oryzae RNA polymerase II subunit A C-terminal domain phosphatase ssu72 (ssu72) CSB-YP651180DPA
CSB-EP651180DPA
CSB-BP651180DPA
CSB-MP651180DPA
CSB-EP651180DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Mitochondrial distribution and morphology protein 12 (mdm12) CSB-YP651181DPA
CSB-EP651181DPA
CSB-BP651181DPA
CSB-MP651181DPA
CSB-EP651181DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae ATP-dependent RNA helicase rok1 (rok1), partial CSB-YP651182DPA
CSB-EP651182DPA
CSB-BP651182DPA
CSB-MP651182DPA
CSB-EP651182DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Protein rot1 (rot1), partial CSB-YP651183DPA
CSB-EP651183DPA
CSB-BP651183DPA
CSB-MP651183DPA
CSB-EP651183DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable alpha-galactosidase A (aglA), partial CSB-YP651184DPA
CSB-EP651184DPA
CSB-BP651184DPA
CSB-MP651184DPA
CSB-EP651184DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable beta-glucosidase E (bglE), partial CSB-YP651185DPA
CSB-EP651185DPA
CSB-BP651185DPA
CSB-MP651185DPA
CSB-EP651185DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Methylthioribulose-1-phosphate dehydratase (mde1) CSB-YP651186DPA
CSB-EP651186DPA
CSB-BP651186DPA
CSB-MP651186DPA
CSB-EP651186DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Autophagy-related protein 9 (atg9), partial CSB-YP651187DPA
CSB-EP651187DPA
CSB-BP651187DPA
CSB-MP651187DPA
CSB-EP651187DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Echis ocellatus Zinc metalloproteinase-disintegrin Eoc1 (Svmp3-Eoc1) CSB-YP651188EJL
CSB-EP651188EJL
CSB-BP651188EJL
CSB-MP651188EJL
CSB-EP651188EJL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rangifer tarandus NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP651189RBL1
CSB-EP651189RBL1
CSB-BP651189RBL1
CSB-MP651189RBL1
CSB-EP651189RBL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Coiled-coil domain-containing protein YLR146W-A (YLR146W-A) CSB-YP651190SVG
CSB-EP651190SVG
CSB-BP651190SVG
CSB-MP651190SVG
CSB-EP651190SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YDR461C-A (YDR461C-A) CSB-YP651191SVG
CSB-EP651191SVG
CSB-BP651191SVG
CSB-MP651191SVG
CSB-EP651191SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative defensin-like protein 20 (At5g52605) CSB-YP651192DOA
CSB-EP651192DOA
CSB-BP651192DOA
CSB-MP651192DOA
CSB-EP651192DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Defensin-like protein 272 (At5g60553) CSB-YP651193DOA
CSB-EP651193DOA
CSB-BP651193DOA
CSB-MP651193DOA
CSB-EP651193DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative defensin-like protein 304 (At5g46877) CSB-YP651194DOA
CSB-EP651194DOA
CSB-BP651194DOA
CSB-MP651194DOA
CSB-EP651194DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Defensin-like protein 276 (At5g37474) CSB-YP651195DOA
CSB-EP651195DOA
CSB-BP651195DOA
CSB-MP651195DOA
CSB-EP651195DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative defensin-like protein 48 (At5g19175) CSB-YP651196DOA
CSB-EP651196DOA
CSB-BP651196DOA
CSB-MP651196DOA
CSB-EP651196DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Cyclin-D5-1 (CYCD5-1) CSB-YP651197DOA
CSB-EP651197DOA
CSB-BP651197DOA
CSB-MP651197DOA
CSB-EP651197DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative defensin-like protein 89 (At4g13968) CSB-YP651198DOA
CSB-EP651198DOA
CSB-BP651198DOA
CSB-MP651198DOA
CSB-EP651198DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative defensin-like protein 102 (At4g08028) CSB-YP651199DOA
CSB-EP651199DOA
CSB-BP651199DOA
CSB-MP651199DOA
CSB-EP651199DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>